Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system.

Loganathan T, Jit M, Hutubessy R, Ng CW, Lee WS, Verguet S.

Trop Med Int Health. 2016 Aug 9. doi: 10.1111/tmi.12766. [Epub ahead of print]

PMID:
27503549
2.

Assessing dengue vaccination impact: Model challenges and future directions.

Recker M, Vannice K, Hombach J, Jit M, Simmons CP.

Vaccine. 2016 Jul 22. pii: S0264-410X(16)30562-X. doi: 10.1016/j.vaccine.2016.06.082. [Epub ahead of print]

3.

Oral Human Papillomavirus Infection in Men Who Have Sex with Men: A Systematic Review and Meta-Analysis.

King EM, Oomeer S, Gilson R, Copas A, Beddows S, Soldan K, Jit M, Edmunds WJ, Sonnenberg P.

PLoS One. 2016 Jul 6;11(7):e0157976. doi: 10.1371/journal.pone.0157976. eCollection 2016.

4.

Chlamydia sequelae cost estimates used in current economic evaluations: does one-size-fit-all?

Ong KJ, Soldan K, Jit M, Dunbar JK, Woodhall SC.

Sex Transm Infect. 2016 Jun 9. pii: sextrans-2016-052597. doi: 10.1136/sextrans-2016-052597. [Epub ahead of print]

PMID:
27288417
5.

The economic burden of dengue: no longer invisible or unavoidable.

Jit M.

Lancet Infect Dis. 2016 Aug;16(8):873-4. doi: 10.1016/S1473-3099(16)30001-9. Epub 2016 Apr 16. No abstract available.

PMID:
27091091
6.

Correction: Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis.

Wu JT, Jit M, Zheng Y, Leung K, Xing W, Yang J, Liao Q, Cowling BJ, Yang B, Lau EH, Takahashi S, Farrar JJ, Grenfell BT, Leung GM, Yu H.

PLoS Med. 2016 Apr 6;13(4):e1002013. doi: 10.1371/journal.pmed.1002013. eCollection 2016 Apr.

7.

The Hidden Health and Economic Burden of Rotavirus Gastroenteritis in Malaysia: An Estimation Using Multiple Data Sources.

Loganathan T, Ng CW, Lee WS, Jit M.

Pediatr Infect Dis J. 2016 Jun;35(6):601-6. doi: 10.1097/INF.0000000000001129.

PMID:
27008464
8.

Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis.

Wu JT, Jit M, Zheng Y, Leung K, Xing W, Yang J, Liao Q, Cowling BJ, Yang B, Lau EH, Takahashi S, Farrar JJ, Grenfell BT, Leung GM, Yu H.

PLoS Med. 2016 Mar 15;13(3):e1001975. doi: 10.1371/journal.pmed.1001975. eCollection 2016 Mar. Erratum in: PLoS Med. 2016 Apr;13(4):e1002013.

9.

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Brotherton JM, Jit M, Gravitt PE, Brisson M, Kreimer AR, Pai SI, Fakhry C, Monsonego J, Franceschi S.

Int J Cancer. 2016 Aug 1;139(3):510-7. doi: 10.1002/ijc.30063. Epub 2016 Mar 22. Review.

PMID:
26916230
10.

Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot.

Atkins K, van Hoek AJ, Watson C, Baguelin M, Choga L, Patel A, Raj T, Jit M, Griffiths U.

BMJ Open. 2016 Feb 16;6(2):e009739. doi: 10.1136/bmjopen-2015-009739.

11.

Current Global Pricing For Human Papillomavirus Vaccines Brings The Greatest Economic Benefits To Rich Countries.

Herlihy N, Hutubessy R, Jit M.

Health Aff (Millwood). 2016 Feb;35(2):227-34. doi: 10.1377/hlthaff.2015.1411.

PMID:
26858374
12.

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?

Jit M, Hutubessy R.

Appl Health Econ Health Policy. 2016 Jun;14(3):245-52. doi: 10.1007/s40258-016-0224-7.

13.

A systematic review of the social and economic burden of influenza in low- and middle-income countries.

de Francisco Shapovalova N, Donadel M, Jit M, Hutubessy R.

Vaccine. 2015 Nov 27;33(48):6537-44. doi: 10.1016/j.vaccine.2015.10.066. Epub 2015 Oct 25. Review.

PMID:
26597032
14.

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.

Penny MA, Verity R, Bever CA, Sauboin C, Galactionova K, Flasche S, White MT, Wenger EA, Van de Velde N, Pemberton-Ross P, Griffin JT, Smith TA, Eckhoff PA, Muhib F, Jit M, Ghani AC.

Lancet. 2016 Jan 23;387(10016):367-75. doi: 10.1016/S0140-6736(15)00725-4. Epub 2015 Nov 6.

15.

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.

Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O.

Pharmacoeconomics. 2016 Mar;34(3):227-44. doi: 10.1007/s40273-015-0335-2.

16.

The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.

Yang J, Jit M, Leung KS, Zheng YM, Feng LZ, Wang LP, Lau EH, Wu JT, Yu HJ.

Infect Dis Poverty. 2015 Oct 6;4:44. doi: 10.1186/s40249-015-0077-6.

17.

What makes an eLife paper in epidemiology and global health?

Jit M, Franco E, Jha P.

Elife. 2015 Oct 7;4. doi: 10.7554/eLife.11326.

18.

Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making?

Pan XF, Griffiths UK, Pennington M, Yu H, Jit M.

Vaccine. 2015 Nov 17;33(46):6164-72. doi: 10.1016/j.vaccine.2015.09.081. Epub 2015 Oct 2. Review.

PMID:
26435189
19.

Fewer than three doses of HPV vaccine.

Jit M, Laprise JF, Choi YH, Brisson M.

Lancet Oncol. 2015 Sep;16(9):e423-4. doi: 10.1016/S1470-2045(15)00229-6. No abstract available.

PMID:
26370345
20.

High-dose influenza vaccines make economic sense for older people.

Jit M.

Lancet Infect Dis. 2015 Dec;15(12):1372-3. doi: 10.1016/S1473-3099(15)00272-8. Epub 2015 Sep 8. No abstract available. Erratum in: Lancet Infect Dis. 2015 Dec;15(12):1375.

PMID:
26362173
Items per page

Supplemental Content

Write to the Help Desk